Company: SWKH
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001628280-25-040420
Chunk: 74

Company: SWK Holdings Corp
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 74
---
 made to align with the overall strategy to focus on the specialty finance business. The following table summarizes the assets and liabilities held for sale:June 30, 2025December 31, 2024Assets:Inventory$374 $354 Property & equipment, net4,755 4,635 Intangible assets, net209 209 Other non-current assets1,150 1,200 Total assets held for sale, net$6,488 $6,398 Liabilities:Accounts payable & accrued liabilities$263 $268 Other non-current liabilities1,015 987 Total liabilities held for sale$1,278 $1,255 During neither the six months ended June 30, 2025 nor the year ended December 31, 2024, there was not a strategic shift for the Company, and accordingly, the Pharmaceutical Development segment does not meet the criteria to be classified as a discontinued 

14

operation. As a result, we will continue to report our operational results for the Pharmaceutical Development segment until the sale. The following table shows the net loss before taxes for MOD3 (in thousands):Three Months Ended June 30,Six Months Ended June 30,2025202420252024Net loss before taxes$18 $(1,736)$(518)$(3,192)

On July 15, 2025, the Company, MOD3, and Aptar closed the asset purchase agreement (the "Purchase Agreement") for the sale and assignment of the Assets to Aptar (the "Asset Sale") for an aggregate purchase price of approximately $6.9 million which includes cash previously paid by Aptar in accordance with the Option Agreement. 

Note 5. Marketable Investments

Investments in corporate debt and equity securities consist of the following (in thousands):June 30, 2025December 31, 2024Corporate debt securities$6 $21 Equity securities597 559 Total marketable investments$603 $580  The amortized cost basis amounts, gross unrealized holding gains, gross unrealized holding losses and fair values of available-for-sale debt securities are as follows (in thousands):Amortized CostGross Unrealized Gains Gross Unrealized LossesFair ValueJune 30, 2025$6 $— $— $6 December 31, 2024$21 $— $— $21 Equity SecuritiesOn May 29, 202